Breaking News

Lifecore Biomedical Sells Excess Capital Equipment for $17M

Aims to enhance its financial position by monetizing unused equipment.

Author Image

By: Charlie Sternberg

Associate Editor

Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has entered into a sales agreement with a non-competitive buyer for the company’s previously purchased, but not yet installed, high-speed, multi-purpose 10-head isolator filler. Under the terms of the agreement, the buyer will pay Lifecore an aggregate purchase price of $17 million in exchange for the 10-head filler. “As we continue to execute our growth strategy, we have continued to c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters